ESTADÍSTICA MULTIVARIANTE APLICADA
Escuela de doctorado
Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (35)
2023
-
ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 479-482
-
Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response
Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 1, pp. 1-13
-
Role of Different Health Care Professionals in the Management of Asthma Patients: The GEMA-FORUM IV Task Force
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 3, pp. 214-217
2022
-
Cluster Subanalysis of Patients With Severe Asthma Who Responded to Omalizumab
Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 3, pp. 213-215
2021
-
Clinical recommendations for the management of biological treatments in severe asthma patients: A consensus statement
Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 1, pp. 36-43
-
Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score
Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 7, pp. 2725-2731
2020
-
Fenoma study: Achieving full control in patients with severe allergic asthma
Journal of Asthma and Allergy, Vol. 13, pp. 159-166
-
Referral recommendations for adult emergency department patients with exacerbated asthma
Emergencias, Vol. 32, Núm. 4, pp. 258-268
2019
-
Benralizumab: A New approach for the treatment of severe eosinophilic asthma
Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 2, pp. 84-93
-
Selection of biologics in severe asthma: A multifaceted algorithm
Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 4, pp. 325-328
-
Severe asthma phenotypes in patients controlled with omalizumab: A real-world study
Respiratory Medicine, Vol. 159
-
Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018
Allergy: European Journal of Allergy and Clinical Immunology
2018
-
Consensus document on dog and cat allergy
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 6, pp. 1206-1222
2017
-
Allergy rhinitis: Similarities and differences between children and adults
Rhinology, Vol. 55, Núm. 4, pp. 326-331
-
Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN Study
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 72, Núm. 6, pp. 959-966
-
Omalizumab is equally effective in persistent allergic oral corticosteroid-dependent asthma caused by either seasonal or perennial allergens: A pilot study
International Journal of Molecular Sciences, Vol. 18, Núm. 3
2016
-
Allergic rhinitis causes loss of smell in children: The OLFAPEDRIAL study
Pediatric Allergy and Immunology, Vol. 27, Núm. 8, pp. 867-870
2015
-
Clinical management and use of health care resources in the treatment of nasal polyposis in Spanish allergy centers: The POLAR study
Journal of Investigational Allergology and Clinical Immunology, Vol. 25, Núm. 4, pp. 276-282
-
Relationship between serum total IgE and disease severity in patients with allergic asthma in Spain
Journal of Investigational Allergology and Clinical Immunology, Vol. 25, Núm. 2, pp. 120-127
2013
-
Analysis of comorbidities and therapeutic approach for allergic rhinitis in a pediatric population in Spain
Pediatric Allergy and Immunology, Vol. 24, Núm. 7, pp. 678-684